Clinical Trial

Supportive Outcomes Through Listening, Validation, and Empowerment

Study acronym: SOLVE
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated January 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This research aims to pilot an intervention that will provide practitioners and clinicians with evidenced-based behavioral health strategies for working with autistic adults. The findings will contribute to the needed, yet sparse research of evidence-based behavioral health interventions for this population. The guiding research aims for this study are: 1. To implement a small-scale pilot study aimed at refining the Solution Focused Brief Therapy (SFBT) and protocol for use with autistic adults based on clinician expertise and lived experience. 2. To test the feasibility and acceptability of the SFBT. Namely, how well the intervention is received by this population and if participants can attend and engage in all 4 sessions. 3. To evaluate outcomes before and after the intervention and assess for any improvements through valid and reliable measurements of behavioral health outcomes. This research aims to answer the following research questions: 1. What is the retention rate of participants in the 4-weekly sessions of the SOLVE program? 2. Do participants show progress in their self-identified goals after the intervention? 3. What are the experiences and satisfaction rates of participants in participating in a four-session SFBT intervention? 4. Do participants report higher scores in quality of life and lower depressive and anxiety scores between baseline and immediately post-intervention? The five autistic participants will participate in four one-on-one weekly SFBT sessions conducted by licensed mental health professionals. The intervention is expected to take four to 5 weeks, allowing for cancelations and rescheduling as needed.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06587594
Lead Sponsor University of Texas at Austin
Conditions Autism Spectrum Disorder (ASD)
Enrollment 5 participants
Start Date 2024-08-14
Primary Completion 2025-01-31 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2024-09-19